Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1956 1
1961 6
1962 5
1963 2
1964 4
1965 4
1966 3
1968 3
1969 8
1970 3
1971 3
1972 2
1973 2
1974 11
1975 8
1976 9
1977 10
1978 18
1979 18
1980 24
1981 32
1982 30
1983 40
1984 28
1985 23
1986 20
1987 34
1988 39
1989 38
1990 47
1991 31
1992 52
1993 48
1994 43
1995 52
1996 52
1997 67
1998 69
1999 74
2000 115
2001 100
2002 159
2003 131
2004 150
2005 143
2006 143
2007 145
2008 152
2009 157
2010 171
2011 221
2012 196
2013 176
2014 178
2015 170
2016 182
2017 192
2018 204
2019 197
2020 205
2021 212
2022 213
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

4,420 results
Results by year
Filters applied: . Clear all
Page 1
Current status of immunotherapy for advanced gastric cancer.
Kawazoe A, Shitara K, Boku N, Yoshikawa T, Terashima M. Kawazoe A, et al. Among authors: yoshikawa t. Jpn J Clin Oncol. 2021 Jan 1;51(1):20-27. doi: 10.1093/jjco/hyaa202. Jpn J Clin Oncol. 2021. PMID: 33241322 Review.
A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data.
Chen LT, Satoh T, Ryu MH, Chao Y, Kato K, Chung HC, Chen JS, Muro K, Kang WK, Yeh KH, Yoshikawa T, Oh SC, Bai LY, Tamura T, Lee KW, Hamamoto Y, Kim JG, Chin K, Oh DY, Minashi K, Cho JY, Tsuda M, Sameshima H, Kang YK, Boku N. Chen LT, et al. Among authors: yoshikawa t. Gastric Cancer. 2020 May;23(3):510-519. doi: 10.1007/s10120-019-01034-7. Epub 2019 Dec 20. Gastric Cancer. 2020. PMID: 31863227 Free PMC article. Clinical Trial.
[Preface].
Yoshikawa T, Okamura N. Yoshikawa T, et al. Nihon Yakurigaku Zasshi. 2021;156(6):323. doi: 10.1254/fpj.21040. Nihon Yakurigaku Zasshi. 2021. PMID: 34719561 Japanese. No abstract available.
Intestinal Dysbiosis and Autoimmune Pancreatitis.
Yoshikawa T, Watanabe T, Kamata K, Hara A, Minaga K, Kudo M. Yoshikawa T, et al. Front Immunol. 2021 Mar 23;12:621532. doi: 10.3389/fimmu.2021.621532. eCollection 2021. Front Immunol. 2021. PMID: 33833754 Free PMC article. Review.
CD153/CD30 signaling promotes age-dependent tertiary lymphoid tissue expansion and kidney injury.
Sato Y, Oguchi A, Fukushima Y, Masuda K, Toriu N, Taniguchi K, Yoshikawa T, Cui X, Kondo M, Hosoi T, Komidori S, Shimizu Y, Fujita H, Jiang L, Kong Y, Yamanashi T, Seita J, Yamamoto T, Toyokuni S, Hamazaki Y, Hattori M, Yoshikai Y, Boor P, Floege J, Kawamoto H, Murakawa Y, Minato N, Yanagita M. Sato Y, et al. Among authors: yoshikawa t. J Clin Invest. 2022 Jan 18;132(2):e146071. doi: 10.1172/JCI146071. J Clin Invest. 2022. PMID: 34813503 Free PMC article.
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab.
Boku N, Satoh T, Ryu MH, Chao Y, Kato K, Chung HC, Chen JS, Muro K, Kang WK, Yeh KH, Yoshikawa T, Oh SC, Bai LY, Tamura T, Lee KW, Hamamoto Y, Kim JG, Chin K, Oh DY, Minashi K, Cho JY, Tsuda M, Nishiyama T, Chen LT, Kang YK. Boku N, et al. Among authors: yoshikawa t. Gastric Cancer. 2021 Jul;24(4):946-958. doi: 10.1007/s10120-021-01173-w. Epub 2021 Mar 20. Gastric Cancer. 2021. PMID: 33743112 Free PMC article. Clinical Trial.
Development and validation of deep learning classifiers to detect Epstein-Barr virus and microsatellite instability status in gastric cancer: a retrospective multicentre cohort study.
Muti HS, Heij LR, Keller G, Kohlruss M, Langer R, Dislich B, Cheong JH, Kim YW, Kim H, Kook MC, Cunningham D, Allum WH, Langley RE, Nankivell MG, Quirke P, Hayden JD, West NP, Irvine AJ, Yoshikawa T, Oshima T, Huss R, Grosser B, Roviello F, d'Ignazio A, Quaas A, Alakus H, Tan X, Pearson AT, Luedde T, Ebert MP, Jäger D, Trautwein C, Gaisa NT, Grabsch HI, Kather JN. Muti HS, et al. Among authors: yoshikawa t. Lancet Digit Health. 2021 Oct;3(10):e654-e664. doi: 10.1016/S2589-7500(21)00133-3. Epub 2021 Aug 17. Lancet Digit Health. 2021. PMID: 34417147 Free PMC article.
Gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer (JCOG0501): an open-label, phase 3, randomized controlled trial.
Iwasaki Y, Terashima M, Mizusawa J, Katayama H, Nakamura K, Katai H, Yoshikawa T, Ito S, Kaji M, Kimura Y, Hirao M, Yamada M, Kurita A, Takagi M, Lee SW, Takagane A, Yabusaki H, Hihara J, Boku N, Sano T, Sasako M. Iwasaki Y, et al. Among authors: yoshikawa t. Gastric Cancer. 2021 Mar;24(2):492-502. doi: 10.1007/s10120-020-01136-7. Epub 2020 Nov 16. Gastric Cancer. 2021. PMID: 33200303 Clinical Trial.
4,420 results